ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 238 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $216,000 | -79.4% | 15,354 | -65.9% | 0.02% | -83.2% |
| Q4 2021 | $1,050,000 | -8.8% | 44,980 | -4.7% | 0.11% | -4.5% |
| Q2 2021 | $1,151,000 | +93.4% | 47,189 | +284.1% | 0.11% | +62.3% |
| Q2 2020 | $595,000 | -32.5% | 12,285 | -40.4% | 0.07% | -19.8% |
| Q4 2019 | $881,000 | -46.9% | 20,601 | -55.3% | 0.09% | -33.3% |
| Q3 2019 | $1,660,000 | +230.0% | 46,114 | +146.2% | 0.13% | +360.7% |
| Q1 2019 | $503,000 | +35.2% | 18,727 | -18.5% | 0.03% | +40.0% |
| Q4 2018 | $372,000 | – | 22,975 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
| SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
| HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
| Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
| GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
| EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
| Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
| Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |